ImportRefusal LogoImportRefusal

Reckitt Benckiser Pakistan Ltd.

⚠️ Moderate Risk

FEI: 3004524689 • Karachi • PAKISTAN

FEI

FEI Number

3004524689

📍

Location

Karachi

🇵🇰

Country

PAKISTAN
🏢

Address

F-18 S.i.t.e., , Karachi, , Pakistan

Moderate Risk

FDA Import Risk Assessment

32.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
8
Unique Violations
2/19/2021
Latest Refusal
6/21/2004
Earliest Refusal

Score Breakdown

Violation Severity
56.5×40%
Refusal Volume
28.8×30%
Recency
2.1×20%
Frequency
3.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1185×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3363×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3442×

WARNINGS

It appears to lack adequate warning against use in a pathological condition or by children where it may be dangerous to health or against an unsafe dose, method, administering duration, application, in manner/form, to protect users.

38962×

NOCONTACT

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act because it appears to be a nonprescription drug that is misbranded within the meaning of Section 502(x) of the FD&C Act in that the product label fails to bear a domestic address or phone number through which the responsible person may receive a report of a serious adverse event with such drug.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

Refusal History

DateProductViolationsDivision
2/19/2021
64AAL99DISINFECTANT N.E.C.
118NOT LISTED
336INCONSPICU
344WARNINGS
3896NOCONTACT
Division of Northeast Imports (DNEI)
2/19/2021
64AAL99DISINFECTANT N.E.C.
118NOT LISTED
336INCONSPICU
344WARNINGS
3896NOCONTACT
Division of Northeast Imports (DNEI)
5/14/2009
61FAK21CHLOROXYLENOL (ANTI-BACTERIAL) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
Los Angeles District Office (LOS-DO)
5/14/2009
61FAK21CHLOROXYLENOL (ANTI-BACTERIAL) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
Los Angeles District Office (LOS-DO)
6/21/2004
61FBY21CHLOROXYLENOL (ANTI-BACTERIAL) (NOT ANTIBIOTIC)
118NOT LISTED
16DIRECTIONS
333LACKS FIRM
336INCONSPICU
473LABELING
Detroit District Office (DET-DO)

Frequently Asked Questions

What is Reckitt Benckiser Pakistan Ltd.'s FDA import refusal history?

Reckitt Benckiser Pakistan Ltd. (FEI: 3004524689) has 5 FDA import refusal record(s) in our database, spanning from 6/21/2004 to 2/19/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Reckitt Benckiser Pakistan Ltd.'s FEI number is 3004524689.

What types of violations has Reckitt Benckiser Pakistan Ltd. received?

Reckitt Benckiser Pakistan Ltd. has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Reckitt Benckiser Pakistan Ltd. come from?

All FDA import refusal data for Reckitt Benckiser Pakistan Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.